Invitae Corporation. (NVTA) CEO Sean George on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/06/20
Invitae to Announce Third Quarter 2020 Financial Results on Thursday, November 5, 2020PRNewsWire • 10/23/20
Are Options Traders Betting on a Big Move in Invitae (NVTA) Stock?Zacks Investment Research • 10/07/20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients WorldwidePRNewsWire • 10/05/20
Multi-site study to evaluate the role of testing guidelines in ensuring access to genetic information for men with prostate cancerPRNewsWire • 09/03/20
Invitae to Participate in the Morgan Stanley Virtual Global Healthcare ConferencePRNewsWire • 09/01/20
Invitae Corporation's (NVTA) CEO Sean George on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/05/20
Invitae Reports $46.2 Million in Revenue Driven by More Than 120,000 Samples Accessioned in the Second Quarter of 2020PRNewsWire • 08/04/20
Analysts Estimate Invitae (NVTA) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 07/28/20
2 Companies In The Fast-Growing Market For Molecular Diagnostics And Genetic TestingSeeking Alpha • 07/14/20